Propel Bio Management, LLC

Propel Bio Management LLC is a registered investment adviser established in 2022 and located in Los Angeles, California. The firm specializes in providing discretionary investment advisory services to Propel Bio Partners, L.P. (a private fund) and sub-advisory services to the Simplify Propel Bio Opportunities ETF. Propel manages each client's portfolio based on established investment objectives, strategies, and restrictions, without tailoring services to individual needs. For the private fund, Propel charges asset-based management fees and may receive performance-based compensation. The ETF pays a sub-advisory fee as per the prospectus. Propel's investment strategy for the private fund focuses on seed and venture capital investing in life sciences and related fields. The firm's ETF strategy is an actively managed opportunistic multi-asset approach, including common stock, preferred stock, convertible bonds, and other debt instruments. Propel discloses potential conflicts of interest related to soft dollar benefits, personal trading practices, and proxy voting. The firm maintains a Code of Ethics to prioritize client interests and requires pre-clearance of personal transactions. Propel reviews and monitors client portfolios regularly, employs independent custodians, and provides audited financial statements to private fund investors. Propel exercises investment discretion for its clients and votes proxies based on financial interests. The firm does not have financial commitments impairing its ability to meet obligations or bankruptcy history. Clients can request information on proxy voting policies and procedures or obtain a copy of the firm's Code of Ethics.